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Giemsa-banding partial karyograms of 1q triplication and its 
representative ideogram. The arrows indicate a trp(1)(q21q32) 
chromosome. 
Clinics and pathology 
Disease 
Acute myeloid leukemia (AML), myelodysplastic  
 
syndrome (MDS), Burkitt lymphomas or non-Burkitt  
type lymphomas, acute lymphoblastic leukemia (ALL), 
multiple myeloma (MM), myeloproliferative neoplasm 
(MPN) and Fanconi anemia. 
Note 
29 cases have been reported in the literature. 
Phenotype/cell stem origin 
Rare secondary karyotypic event in various 
hematologic malignancies; AML/MDS (8 cases), 
Lymphoma (9 cases), ALL (6 cases), MM (3 cases), 
MPN (2 cases), Fanconi anemia without other 
hematologic malignancies (1 case). 
Epidemiology 
Male predominance (71%), patients ranged in age from
14 to 69 (median 41.5 years). 
Prognosis 
Most of 1q triplication cases did not provide detail d 
information for the patients' survival. Although parti l 
duplication/triplication of 1q or trisomy 1 was reported 
to be correlated with a poor outcome, further studies 




1q triplication is a distinct secondary chromosomal 
abnormality. Most repeated region (tandem triplication) 
of 1q is q21-q32 (33% of total cases). 
Additional anomalies 
Most cases showed a complex karyotype except three 
solitary abnormalities of trp(1)(q) cases. 
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Genes involved and proteins 
Note 
The gene involved in trp(1)(q) is unknown. However, it 
was suggested that the most common region of 
duplication, 1q23-q24, harbors genes associated with
tumor cell invasiveness. 
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